Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ingria Pratama Capitalindo Tbk. (GRIA) vs Merck Tbk. (MERK) Price & Performance

Ingria Pratama Capitalindo Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Ingria Pratama Capitalindo Tbk. vs Merck Tbk. — how do they compare? Ingria Pratama Capitalindo Tbk. trades at Rp148 (market cap 1.09T, 1.12M 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Ingria Pratama Capitalindo Tbk. is more actively traded (1.12M versus 29.1K). Which is the better fit depends on your goals.

GRIAMERK
Market Cap
1.09T1.75T
Volume
1.12M29.1K
Lot
11.16K291
Turnover
164.8M113.37M
Average Price
147.633,895.98
Value
164.8M113.37M
Indicative Equilibrium Price
1483,890
Indicative Equilibrium Volume
2231

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GRIA
View details
MERK
View details

About Ingria Pratama Capitalindo Tbk.

PT Ingria Pratama Capitalindo Tbk (the “Company”) was established based on Notarial Deed No. 04 dated 8 May 2013 of Euis Widari, S.H. The Company commenced its operationalactivity with purchases of land in 2017.

Read more on GRIA

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK